Glenmede Trust CO Na Sorrento Therapeutics, Inc. Transaction History

Glenmede Trust CO Na

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 16, 2022	BUY	$1.51 - $2.88 $17,452 - $33,287	11,558 New	11,558 $18,000
Q1 2021 May 18, 2021	SELL	$7.03 - $16.51 $205,676 - $483,033	-29,257 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$5.76 - $11.95 $702 - $1,457	122 Added 0.42%	29,257 $199,000
Q3 2020 Nov 16, 2020	SELL	$6.17 - $18.82 $1,234 - $3,764	-200 Reduced 0.68%	29,135 $324,000
Q2 2020 Aug 14, 2020	BUY	$1.73 - $6.76 $346 - $1,352	200 Added 0.69%	29,335 $184,000
Q3 2017 Nov 14, 2017	BUY	$1.63 - $2.0 $47,490 - $58,270	29,135	29,135 $0

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.